Opioids
The Centers for Medicare & Medicaid Services will host a Feb. 14 call for clinicians and other interested stakeholders on new opioid policies for Medicare Part D plans that took effect Jan. 1.
The Centers for Medicare & Medicaid Services will host a Feb. 14 call for clinicians and other interested stakeholders on new opioid policies for Medicare Part D plans that took effect Jan. 1.
Also in this weekly roundup of health care news: Providence St. Joseph Health launches population health company; Aetna, others try new approach to educate doctors about opioid alternatives.
The Health Resources and Services Administration's Federal Office of Rural Health Policy plans to award about 75 grants of up to $1 million each to expand opioid and other substance use disorder services in high-risk rural communities.
The White House Office of National Drug Control Policy yesterday released its national drug control strategy, intended to guide federal efforts to reduce the availability and use of illicit drugs and barriers to substance use disorder treatment.
Opioid overdose deaths could reach 81,700 a year by 2025, and 700,400 over a decade, largely due to illicit opioids, according to a study published today in JAMA Network Open.
The National Academies of Sciences, Engineering, and Medicine Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain will host a Feb. 4 public workshop as part of its information gathering activities.
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug Administration today released model consumer-friendly labels for prospective OTC versions of the drug.
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014 and March 2017 than patients in large metropolitan areas.
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and staffing investments and identify alternative therapies.